1. Home
  2. MEC vs ESPR Comparison

MEC vs ESPR Comparison

Compare MEC & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$25.77

Market Cap

525.7M

Sector

Industrials

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
ESPR
Founded
1945
2008
Country
United States
United States
Employees
2400
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
525.7M
731.9M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
MEC
ESPR
Price
$25.77
$3.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$24.33
$8.75
AVG Volume (30 Days)
198.1K
16.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.66
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$12.10
$0.76
52 Week High
$28.00
$4.18

Technical Indicators

Market Signals
Indicator
MEC
ESPR
Relative Strength Index (RSI) 67.66 70.76
Support Level $17.38 $2.37
Resistance Level N/A $3.18
Average True Range (ATR) 1.55 0.05
MACD 0.17 0.07
Stochastic Oscillator 66.96 96.38

Price Performance

Historical Comparison
MEC
ESPR

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: